CytomX Therapeutics to Announce First Quarter 2019 Financial Results

NEXT STORY
Corbus Pharmaceuticals Completes Enrollment of RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
PREV STORY
Kiniksa Reports First Quarter 2019 Financial Results and Highlights Recent Corporate and Pipeline Activity
Subscribe to PM360
Print Subscription

Experts on Call

Follow Us
Get in touch with PM360 Experts On Call

Ads

You May Also Like

Timothy Keeler, BS-PA is Selected to the American Health Council’s Board of Physicians

NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Timothy ...

author_avatar
NASDAQ Market News

Vical Announces Review of Potential Strategic Transactions

SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that ...

author_avatar
NASDAQ Market News

Diet Doc Announces Their All-Inclusive, Nationwide Medical Weight Loss Service that Enables Dieters Throughout the Country to Connect with the Best Minds in the Business for Safe and Fast Weight Loss

LOS ANGELES, Dec. 30, 2015 (GLOBE NEWSWIRE) -- For many Americans, finding a doctor ...

author_avatar
NASDAQ Market News